Zotarolimus-impurities | Pharmaffiliates

zotarolimus

Zotarolimus is an immunosuppressant. Zotarolimus failed Abbott's primary endpoint to bring their stent/drug delivery system to market.Reference standards of Zotarolimus API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Zotarolimus-d3
    [catalogue_number] => PA STI 087950
    [category_ids] => ,69,71,78,70,82,98,
    [chemical_name] => 
    [weight] => 969.23
    [form] => C52H76D3N5O12
    [cas] => NA
    [pslug] => zotarolimus-d3-pasti087950
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 087950

Zotarolimus-d3


  • Catalogue No.:PA STI 087950

  • CAS :

    NA

  • Molecular Formula : C52H76D3N5O12

  • Molecular Weight : 969.23